Morgan Stanley »

Sonnet Biotherapeutc Hldng I shares owned by Morgan Stanley

Quarter-by-quarter ownership of Sonnet Biotherapeutc Hldng I (SONN) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Sonnet Biotherapeutc Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Sonnet Biotherapeutc Hldng I held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sonnet Biotherapeutc Hldng I by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2024-06-30 $4 4 1.00
2024-03-31 $10 6 1.83
2023-12-31 $105 61 1.74
2023-09-30 $407 142 2.87

More positions owned by Morgan Stanley

Microsoft Corporation (MSFT)
Microsoft Corporation (MSFT)
Apple (AAPL)
Apple (AAPL)
NVIDIA Corporation (NVDA)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Meta Platforms Cl A (META)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)

View all positions for Morgan Stanley

Top funds holding Sonnet Biotherapeutc Hldng I

Armistice Capital
Vanguard Group
Tower Research Capital
BlackRock
Morgan Stanley

View all funds holding Sonnet Biotherapeutc Hldng I